
Manoguard 250mg/250mg Tablet
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Tranexamic Acid (250mg) + Ethamsylate (250mg)
Overview Manoguard 250mg/250mg Tablet
Tranexamic acid/mefenamic acid 250mg/250mg tablets are prescribed to manage excessive menstrual bleeding. This dual-action medication inhibits clot breakdown, thereby reducing heavy flow. It also enhances platelet aggregation, further promoting clotting. Dosage is flexible—with or without food—but consistency (same time daily) is recommended. Follow your physician's prescribed duration. Missed doses should be taken immediately upon recall; complete the entire course even with symptom improvement. Abrupt cessation requires medical consultation. Common adverse effects may include nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is possible; increased fluid intake is advised to prevent dehydration. If no menstrual improvement is seen after three cycles, consult your doctor. Prior to use, inform your doctor of any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other concurrent medications. Regular eye examinations may be requested during treatment.
Primary Ingredients of Manoguard 250mg/250mg Tablet
No text provided to rephrase.
Uses of Manoguard 250mg/250mg Tablet
Profound menstrual blood loss
Major Benefits of Manoguard 250mg/250mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Manoguard 250 mg/250 mg tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Manoguard 250mg/250mg Tablet:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use Manoguard 250mg/250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Manoguard 250 mg/250 mg tablets can be consumed with or without food, though consistent timing is recommended.
How Manoguard 250mg/250mg Tablet works:
Each Manoguard 250 mg/250 mg tablet combines tranexamic acid and ethamsylate, two agents that help manage bleeding. Tranexamic acid, an antifibrinolytic, stabilizes blood clots by inhibiting their breakdown, thus reducing excessive blood loss. Ethamsylate, a hemostatic agent, promotes blood clot formation by enhancing platelet aggregation, and additionally controls capillary bleeding.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Manoguard 250 mg/250 mg tablets and alcohol can result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Manoguard 250 mg/250 mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Manoguard 250 mg/250 mg Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Manoguard 250 mg/250 mg Tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Manoguard 250 mg/250 mg tablets. Dosage modifications for Manoguard 250 mg/250 mg tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Manoguard 250 mg/250 mg tablets in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Manoguard 250mg/250mg Tablet :
Should you forget to take a Manoguard 250 mg/250 mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Manoguard 250mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
